Scientists “Up Close” at the Parliamentary Evening in Berlin

On February 2, 2015 a Parliamentary Evening took place in Berlin for all German Centres for Health Research (DZG). State secretary Thomas Rachel gave an overview of the progress of these research collaborations in the fight against six major diseases. The DZD, for example, has developed a novel drug candidate for the treatment of type 2 diabetes*.

One representative of each DZG presented his or her center in a moderated presentation round. Prof. Martin Hrabě de Angelis, DZD board member and director of the Institute of Experimental Genetics at Helmholtz Zentrum München, pointed out that translational research is a key success factor for the DZD. He also stressed that long-term institutional funding is essential also in the future to attract the most talented scientists to the DZG. Only in this way can sustainable solutions be found to treat serious diseases that are widespread in the population.

In the interactive part of the event the guests had the opportunity to talk with the scientists. At the tables for each center, research highlights were displayed in graphics. The innovative concept led the scientists to supplement their presentations and to respond directly to questions. Along with Prof. Martin Hrabě de Angelis (on the left in the photo), the other experts representing the DZD were Prof. Hans-Ulrich Häring, DZD board member and medical director of the Department of Internal Medicine IV of the Tübingen University Hospital, Prof. Michael Roden (on the right in the photo) DZD board member and scientific director of the German Diabetes Center in Düsseldorf, Prof. Annette Schürmann, DZD speaker and head of the Department of Experimental Diabetology at the German Institute of Human Nutrition Potsdam-Rehbrücke and Dr. Carolin Daniel, young investigators group leader at Helmholtz Zentrum München. Following the discussion round, the participants had the opportunity to determine their own personal diabetes risk with the DIfE – GERMAN DIABETES RISK TEST®.

The German Centres for Health Research (DZG) are a joint initiative to meet the challenges of the most serious diseases that are widespread in the population:
• Diabetes: German Center for Diabetes Research (DZD)
• Cancer: German Consortium for Translational Cancer Research (DKTK)
• Cardiovascular diseases: German Centre for Cardiovascular Research (DZHK)
• Infectious diseases: German Center for Infection Research (DZIF)
• Lung diseases: German Center for Lung Research (DZL)
• Neurodegenerative diseases: German Center for Neurodegenerative Diseases (DZNE)

More information about the German Centres for Health Research can be found at:

* Novel drug candidate to treat type 2 diabetes